Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass...
Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen
About this item
Full title
Author / Creator
Publisher
United States: OceanSide Publications, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: OceanSide Publications, Inc
Subjects
More information
Scope and Contents
Contents
Specific immunotherapy is a well-established treatment for allergic rhinoconjunctivitis; conventional regimens are lengthy, however, reducing convenience and cost-effectiveness. This study evaluated the efficacy and safety of an ultrashort course (four doses) of the immunotherapy Grass
Modified Allergen Tyrosine Adsorbate (Allergy Therapeutics,...
Alternative Titles
Full title
Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_21535913
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_21535913
Other Identifiers
ISSN
1088-5412
E-ISSN
1539-6304
DOI
10.2500/aap.2011.32.3453
